Polyacid glycopeptide derivatives

Details Polyacid glycopeptide derivatives Polyacid glycopeptide derivatives

2006-07-11

2006-07-11

Weber, Jon (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S317000, C530S322000

Reexamination Certificate

active

07074760

ABSTRACT:
Disclosed are derivatives of glycopeptides that are substituted at the C-terminus with a substituent that comprises two or more (e.g. 2, 3, 4, or 5) carboxy (CO2H) groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.

REFERENCES:
patent: 4643987 (1987-02-01), Nagarajan et al.
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 4727064 (1988-02-01), Pitha
patent: 4983586 (1991-01-01), Bodor
patent: 5024998 (1991-06-01), Bodor
patent: 5591714 (1997-01-01), Nagarajan et al.
patent: 5602112 (1997-02-01), Rubinfeld
patent: 5750509 (1998-05-01), Malabarba et al.
patent: 5840684 (1998-11-01), Cooper et al.
patent: 5916873 (1999-06-01), Cooper et al.
patent: 5919756 (1999-07-01), Cooper et al.
patent: 6392012 (2002-05-01), Judice et al.
patent: 6444786 (2002-09-01), Judice et al.
patent: 6620781 (2003-09-01), Linsell et al.
patent: 6770621 (2004-08-01), Linsell et al.
patent: 0218 099 (1987-04-01), None
patent: 0 667 353 (1995-08-01), None
patent: 0 816 378 (1998-01-01), None
patent: WO 88/06600 (1988-09-01), None
patent: WO 94/12217 (1994-06-01), None
patent: WO 00/39156 (2000-07-01), None
patent: WO 00/54751 (2000-09-01), None
patent: WO 00/59528 (2000-10-01), None
patent: WO 01/97851 (2001-12-01), None
patent: WO 01/98326 (2001-12-01), None
patent: WO 01/98327 (2001-12-01), None
patent: WO 01/98328 (2001-12-01), None
patent: WO 01/98329 (2001-12-01), None
Allen et al., “The Role of Hydrophabic Side Chains as Determinants of Antibacterial Activity of Semisynthetic Glycopeptide Antibiotics”. the Journal of Antibiotics, vol. 50, No. 8, pp. 877-884 (1997).
GE et al., “Vancomycin Derivatives That Inhibit Peptictoglycan Biosynthesis Without Binding D-Ala-D-Ala”, SCIENCE, vol. 284, pp. 507-511 (1999).
Malabarba et al., “Synthesis and Biological Activity ofN83-Carboxypoptides of Teicoplanin and Teicoplanin Aglycone”, the Journal of Antibiotics, vol. XLII, No. 12, pp. 1800-1818 (1989).
Malabarba et al., “Synthesis and Biological Properties ofN83-Carboxamldas of Taicoplanin Antibiotics. Structure-Activity Relationship”. J. Med. Chem., 32, pp. 2450-2480 (1989).
Nagarajan et al., “Synthesis and Antibacterial Evaluation ofN-Akyl Vancomycins”, The Journal of Antibiotics, vol. XLII, No. 1, pp. 63-72 (1989).
Nicolaou et al., “Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics”, Angew. Chem. Int. Ed., 38, pp. 2097-2152 (1999).
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Dertivatives of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, pp. 509-513 (1097).
Pavlov et al., “Chemical Modification of Glycopeptide Antibiotics [VC1]”, Russian Journal of Bioorganic Chemistry, vol. 24, No. 9, pp. 570-587 (1998).
Pavlov et al., “Mono and Double Modified Telcopianin Aglycon Derivatives on the Amino Acid No. 7: Structure activity Relationship”, The Journal of Antibiotics, vol. 51, No. 1, pp. 73-78 (1998).
Rao et al., “Using Capillary Electrophoresis To Study the Electrostatic Interactions Involved in the Association of D-Ala-D-Ala with Vancomycin”, J. Am. Chem. Soc., 199, pp. 9338-9340 (1997).
Zhang et al., “A review of recent applications of cyclodextrins for drug discovery”. Expert Opinon on Therapeutic Patents, 9 (12), pp. 1697-1717 (1998).

Affiliated with

Also associated with

Rating

Polyacid glycopeptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyacid glycopeptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyacid glycopeptide derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3575752